CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 2006 C.E. Unterberg, Towbin Life Sciences Conference on October 30, 2006 at 2:30 PM (ET) at The Palace Hotel, New York, NY.
